IRCT2016061828521N1已完成3 期
Double blind randomized clinical trial in treatment of gastroesophageal reflux disease in children with Myrtus Communis L. (Myrtle) fruit.
Vice Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 year 至 7 years（—）
- 性别
- All
入选标准
- •1.1 to 7 years old children attended to Bahrami’s children hospital gastro-enterology clinic;
- •2.Diagnosis of GERD on the basis of GSQ-YC questionnaire and pediatric gastroenterologist;
- •3.Absence of serious gastrointestinal diseases such as esophagitis, achalasia, gastrointestinal ulcers, IBD (Inflamatory Bowel disease),….;
- •4.Absence of GERD complications such as: esophagitis and ulcers;
- •5.Absence of every serious condition such as severe asthma;
- •6.Absence of gastrointestinal anomalies;
- •7.Absence of cognitive or mental disorders;
- •8.Absence of history of PPIs (Proton Pomp Inhibitors) or H2 Blockers consumption in 1 week before;
- •9.Absence of severe constipation;
- •Exclusion criteria:
- •1.Patient’s lack of tendency to continue the trial;
- •2.Significant conditions which can be considered as drug side effects;
- •3.Exacerbation of GERD symptoms throughout the trial;
- •4.Allergy history to myrtle;
- •5.Significant history of allergy to herbal compounds or food allergy;
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Assessment the Effect of Myrtus Communis L. (Myrtle) fruit in treatment of gastroesophageal reflux diseasegastroesophageal reflux.gastroesophageal reflux without esophagitisIRCT2012072710410N1Vice chancellor for research of Shiraz University of Medical Sciences43
已完成
2 期
short-term co-administration of acid folicfor treating children and adolescents with autismPervasive developmental disorders.Childhood autismIRCT201402043930N33Vice chancellor for research, Shiraz University of Medical sciences40
进行中（未招募）
不适用
Double blind randomized controlled clinical trial to evaluate the efficacy and safety of theophyline in the prevention of nephrotoxicity associated with cisplatin in oncologyEficacia del tratamiento con teofilina para evitar el descenso del 25 %, estimado en el grupo placebo del filtrado glomerular medido con EDTA-Cr51 en pacientes oncológicos bajo tratamiento quimioterápico con cisplatinoMedDRA version: 14.1Level: LLTClassification code 10007096Term: Cancer of lungSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10007107Term: Cancer of ovarySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10043360Term: Testis cancer (excl germ cell)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2006-003014-18-ESVicente Barrio Lucia48
进行中（未招募）
不适用
Double blind, randomized, clinical trial to evaluate efficacy and safety of Phyllanthus amarus versus placebo in the treatment of patients with chronic hepatitis B - CORONAChronic hepatitis BMedDRA version: 9.1Level: PTClassification code 10019731Term: Hepatitis BEUCTR2008-000257-36-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
进行中（未招募）
1 期
oradrenaline plus placebo vs noradrenaline plus terlipressin for thetreatment of septic shockMedDRA version: 20.0Level: LLTClassification code: 10040089Term: Septicemia Class: 10021881MedDRA version: 23.1Level: PTClassification code: 10040070Term: Septic shock Class: 100000004862Septic ShockCTIS2024-514149-12-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla152